When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.Learn More
Glaxo Joins Forces With Sanofi to Develop Coronavirus Vaccine
Before it's here, it's on the Bloomberg Terminal.Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Key Statistics
P/E Ratio10.91
PEGY Ratio1.5476
Shares Outstanding5.02B
Price to Book Ratio4.8768
Price to Sales Ratio2.0289
1 Year Return-15.46%
30 Day Avg Volume7,318,001
EPS1.28
Dividend5.72%
Last Dividend Reported19
Earnings Announcement for Period Ending Q4/2020:02/03/2021
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.Address
980 Great West Road
Brentford
Middlesex
United Kingdom
